| 产品详情 |
| Edit |   |
|---|
| Product Name | SP-2509 |
|---|
| Description | SP-2509 is a reversible inhibitor of Lysine-specific demethylase (LSD1) (IC50 = 13 nM). It has no effect on monoamine oxidases A and B. SP2509 attenuates the binding of LSD1 to CoREST, allowing increased methylation of H3K4 and driving increased expression of p21, p27, and CCAAT/enhancer binding protein α in cultured acute myeloid leukemia (AML) cells. MW: 437.9. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-?(4-?morpholinylsulfonyl)-?benzoic acid (2E)-?2-?[1-?(5-?chloro-?2-?hydroxyphenyl)ethylidene]hydrazide |
|---|
| Gene, Accession, CAS # | CAS: 1423715-09-6 |
|---|
| Catalog # | 9446-25 |
|---|
| Price | |
|---|
| Order / More Info | SP-2509 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|